LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology

To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure. A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 2004-08, Vol.111 (8), p.1604-1617
Hauptverfasser: Varley, Gary A, Huang, David, Rapuano, Christopher J, Schallhorn, Steven, Boxer Wachler, Brian S, Sugar, Alan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1617
container_issue 8
container_start_page 1604
container_title Ophthalmology (Rochester, Minn.)
container_volume 111
creator Varley, Gary A
Huang, David
Rapuano, Christopher J
Schallhorn, Steven
Boxer Wachler, Brian S
Sugar, Alan
description To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure. A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies. This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled. For low (4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile
doi_str_mv 10.1016/j.ophtha.2004.05.016
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66766215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161642004008176</els_id><sourcerecordid>66766215</sourcerecordid><originalsourceid>FETCH-LOGICAL-e292t-d6124a0a30861eab365f9047bce478b7584581d8519e9b981cedf1e82f94c28b3</originalsourceid><addsrcrecordid>eNpNkUFv1DAQhS0EotvCP0DIFzg1wXZsx-ZQaVUVqFiJA3C2HGfS9SqOg-1F5N-TahfU04yePo3evIfQG0pqSqj8cKjjvC97WzNCeE1EvYrP0IYKrive0uY52qwKrSRn5AJd5nwghEjZ8JfoggqmlNZig8pu-_3-Kx5iwvtlhhRnb6__rw7bXPxDsMXncI3t1OPg_0D_VP6ItzjBHFPB3YLLHrANkLyzE7bO9hAWHAd88jqGOMaH5RV6Mdgxw-vzvEI_P939uP1S7b59vr_d7ipgmpWql5RxS2xDlKRgu0aKQRPedg54q7pWKC4U7ZWgGnSnFXXQDxQUGzR3THXNFXp_ujun-OsIuZjgs4NxtBPEYzZStlIyKlbw7Rk8dgF6MycfbFrMv5xW4N0ZsNnZcUh2cj4_4XSrtKQrd3PiYH3rt4dksvMwrcZ8AldMH72hxDwWaA7mFIp5LNAQYVax-QvAj48V</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66766215</pqid></control><display><type>article</type><title>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Varley, Gary A ; Huang, David ; Rapuano, Christopher J ; Schallhorn, Steven ; Boxer Wachler, Brian S ; Sugar, Alan</creator><creatorcontrib>Varley, Gary A ; Huang, David ; Rapuano, Christopher J ; Schallhorn, Steven ; Boxer Wachler, Brian S ; Sugar, Alan ; Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</creatorcontrib><description>To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure. A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies. This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled. For low (&lt;3 diopters [D]) to moderate (3–5 D) hyperopia, results from published studies (levels II and III evidence) have shown that LASIK is effective and predictable in achieving very good to excellent uncorrected visual acuity, achieving postoperative refractions within 1 D of emmetropia, and is safe in terms of minimal loss of best-corrected spectacle vision. Although there are fewer data for hyperopic astigmatism, the results available seem to mirror the data for low to moderate hyperopia (levels II and III evidence). The postoperative results for both uncorrected vision and safety are less compelling, as greater amounts of hyperopia are treated (&gt;4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile with another.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2004.05.016</identifier><identifier>PMID: 15288995</identifier><identifier>CODEN: OPHTDG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Academies and Institutes ; Astigmatism - surgery ; Biological and medical sciences ; Clinical Trials as Topic ; Cornea - surgery ; Humans ; Hyperopia - surgery ; Keratomileusis, Laser In Situ - methods ; Medical sciences ; Ophthalmology ; Societies, Medical ; Technology Assessment, Biomedical ; Treatment Outcome ; United States ; Vision disorders ; Visual Acuity</subject><ispartof>Ophthalmology (Rochester, Minn.), 2004-08, Vol.111 (8), p.1604-1617</ispartof><rights>2004 American Academy of Ophthalmology</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0161642004008176$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15978961$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15288995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Varley, Gary A</creatorcontrib><creatorcontrib>Huang, David</creatorcontrib><creatorcontrib>Rapuano, Christopher J</creatorcontrib><creatorcontrib>Schallhorn, Steven</creatorcontrib><creatorcontrib>Boxer Wachler, Brian S</creatorcontrib><creatorcontrib>Sugar, Alan</creatorcontrib><creatorcontrib>Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</creatorcontrib><title>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure. A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies. This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled. For low (&lt;3 diopters [D]) to moderate (3–5 D) hyperopia, results from published studies (levels II and III evidence) have shown that LASIK is effective and predictable in achieving very good to excellent uncorrected visual acuity, achieving postoperative refractions within 1 D of emmetropia, and is safe in terms of minimal loss of best-corrected spectacle vision. Although there are fewer data for hyperopic astigmatism, the results available seem to mirror the data for low to moderate hyperopia (levels II and III evidence). The postoperative results for both uncorrected vision and safety are less compelling, as greater amounts of hyperopia are treated (&gt;4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile with another.</description><subject>Academies and Institutes</subject><subject>Astigmatism - surgery</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Cornea - surgery</subject><subject>Humans</subject><subject>Hyperopia - surgery</subject><subject>Keratomileusis, Laser In Situ - methods</subject><subject>Medical sciences</subject><subject>Ophthalmology</subject><subject>Societies, Medical</subject><subject>Technology Assessment, Biomedical</subject><subject>Treatment Outcome</subject><subject>United States</subject><subject>Vision disorders</subject><subject>Visual Acuity</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkUFv1DAQhS0EotvCP0DIFzg1wXZsx-ZQaVUVqFiJA3C2HGfS9SqOg-1F5N-TahfU04yePo3evIfQG0pqSqj8cKjjvC97WzNCeE1EvYrP0IYKrive0uY52qwKrSRn5AJd5nwghEjZ8JfoggqmlNZig8pu-_3-Kx5iwvtlhhRnb6__rw7bXPxDsMXncI3t1OPg_0D_VP6ItzjBHFPB3YLLHrANkLyzE7bO9hAWHAd88jqGOMaH5RV6Mdgxw-vzvEI_P939uP1S7b59vr_d7ipgmpWql5RxS2xDlKRgu0aKQRPedg54q7pWKC4U7ZWgGnSnFXXQDxQUGzR3THXNFXp_ujun-OsIuZjgs4NxtBPEYzZStlIyKlbw7Rk8dgF6MycfbFrMv5xW4N0ZsNnZcUh2cj4_4XSrtKQrd3PiYH3rt4dksvMwrcZ8AldMH72hxDwWaA7mFIp5LNAQYVax-QvAj48V</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Varley, Gary A</creator><creator>Huang, David</creator><creator>Rapuano, Christopher J</creator><creator>Schallhorn, Steven</creator><creator>Boxer Wachler, Brian S</creator><creator>Sugar, Alan</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</title><author>Varley, Gary A ; Huang, David ; Rapuano, Christopher J ; Schallhorn, Steven ; Boxer Wachler, Brian S ; Sugar, Alan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e292t-d6124a0a30861eab365f9047bce478b7584581d8519e9b981cedf1e82f94c28b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Academies and Institutes</topic><topic>Astigmatism - surgery</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Cornea - surgery</topic><topic>Humans</topic><topic>Hyperopia - surgery</topic><topic>Keratomileusis, Laser In Situ - methods</topic><topic>Medical sciences</topic><topic>Ophthalmology</topic><topic>Societies, Medical</topic><topic>Technology Assessment, Biomedical</topic><topic>Treatment Outcome</topic><topic>United States</topic><topic>Vision disorders</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varley, Gary A</creatorcontrib><creatorcontrib>Huang, David</creatorcontrib><creatorcontrib>Rapuano, Christopher J</creatorcontrib><creatorcontrib>Schallhorn, Steven</creatorcontrib><creatorcontrib>Boxer Wachler, Brian S</creatorcontrib><creatorcontrib>Sugar, Alan</creatorcontrib><creatorcontrib>Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varley, Gary A</au><au>Huang, David</au><au>Rapuano, Christopher J</au><au>Schallhorn, Steven</au><au>Boxer Wachler, Brian S</au><au>Sugar, Alan</au><aucorp>Ophthalmic Technology Assessment Committee Refractive Surgery Panel, Ameican Academy of Ophthalmology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>111</volume><issue>8</issue><spage>1604</spage><epage>1617</epage><pages>1604-1617</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><coden>OPHTDG</coden><abstract>To describe LASIK for hyperopia, hyperopia with astigmatism, and mixed astigmatism and to examine the evidence to answer questions about the safety and efficacy of the procedure. A literature search conducted for the years 1968 to 2002 retrieved 118 citations. During review and preparation of this article, an additional 2 articles were included. The panel members selected 36 articles for the panel methodologist to review and rate according to the strength of evidence. A level I rating is assigned to properly conducted, well-designed, randomized clinical trials; a level II rating to well-designed cohort and case–control studies; and a level III rating to case series, case reports, and poorly designed prospective and retrospective studies. This assessment describes 5 nonrandomized interventional trials (level II), 3 nonrandomized comparative trials (level III), and 20 noncomparative case series (level III). Additionally, 6 single-case reports (level III) were included because they reported relevant complications, and 2 theoretical analyses (level III) were also considered. This assessment does not compare studies because many variables such as range of hyperopia, follow-up periods, lasers, microkeratomes, techniques, and surgeon experience have not been controlled. For low (&lt;3 diopters [D]) to moderate (3–5 D) hyperopia, results from published studies (levels II and III evidence) have shown that LASIK is effective and predictable in achieving very good to excellent uncorrected visual acuity, achieving postoperative refractions within 1 D of emmetropia, and is safe in terms of minimal loss of best-corrected spectacle vision. Although there are fewer data for hyperopic astigmatism, the results available seem to mirror the data for low to moderate hyperopia (levels II and III evidence). The postoperative results for both uncorrected vision and safety are less compelling, as greater amounts of hyperopia are treated (&gt;4 to 5 D). Utilizing hyperopic LASIK for the treatment of consecutive hyperopia and astigmatism is also effective, although the ability to reduce hyperopic astigmatism after radial keratotomy is limited. Although a variety of ablation profiles can be used to treat mixed astigmatism, very good visual results have been reported (levels II and III evidence). Serious adverse complications leading to permanent visual loss are possible but, fortunately, very rare. There are insufficient data to compare one laser system with another or one ablation profile with another.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15288995</pmid><doi>10.1016/j.ophtha.2004.05.016</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0161-6420
ispartof Ophthalmology (Rochester, Minn.), 2004-08, Vol.111 (8), p.1604-1617
issn 0161-6420
1549-4713
language eng
recordid cdi_proquest_miscellaneous_66766215
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Academies and Institutes
Astigmatism - surgery
Biological and medical sciences
Clinical Trials as Topic
Cornea - surgery
Humans
Hyperopia - surgery
Keratomileusis, Laser In Situ - methods
Medical sciences
Ophthalmology
Societies, Medical
Technology Assessment, Biomedical
Treatment Outcome
United States
Vision disorders
Visual Acuity
title LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: A report by the american academy of ophthalmology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T03%3A31%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LASIK%20for%20hyperopia,%20hyperopic%20astigmatism,%20and%20mixed%20astigmatism:%20A%20report%20by%20the%20american%20academy%20of%20ophthalmology&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Varley,%20Gary%20A&rft.aucorp=Ophthalmic%20Technology%20Assessment%20Committee%20Refractive%20Surgery%20Panel,%20Ameican%20Academy%20of%20Ophthalmology&rft.date=2004-08-01&rft.volume=111&rft.issue=8&rft.spage=1604&rft.epage=1617&rft.pages=1604-1617&rft.issn=0161-6420&rft.eissn=1549-4713&rft.coden=OPHTDG&rft_id=info:doi/10.1016/j.ophtha.2004.05.016&rft_dat=%3Cproquest_pubme%3E66766215%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66766215&rft_id=info:pmid/15288995&rft_els_id=S0161642004008176&rfr_iscdi=true